Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies

Author(s):  Zur Eyal

Issue:  Sep/Oct 2012 - Volume 16, Number 5
View All Articles in Issue

Page(s):  386-393

Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Page 1
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Page 2
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Page 3
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Page 4
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Page 5
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Page 6
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Page 7
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Page 8

Download in electronic PDF format for $75

Abstract:  Sodium cromoglicate (cromolyn sodium) is a very well-known medicine that has been used for many years for various allergic conditions. The topical use of this medicine is less known, and there are no commercial medicines of cream, gel, or lotion in most of the world. This article summarizes the clinical data accumulated from seventeen trials that checked the topical efficacy and safety of sodium cromoglicate and analyzes the clinical implementations of this medicine in the topical treatment of atopic dermatitis and other skin allergies. In addition, this article analyzes the various formulations that have been used in the clinical trials in an attempt to find the optimal formulation. The topical use of sodium cromoglicate seemed to have a promising potential, and implementing the data of this article can allow the compounding pharmacist a very interesting professional activity in very common and widespread allergic pathologies.

Related Keywords: Eyal Zur, RPh, MBA, cromolyn sodium, formulation, atoapic dermatitis, skin disorders, allergic reactions, atopy, anti-inflammatory agent, inflammation, topical preparations, literature review, drug safety, prevention, prophylaxis

Related Categories: DERMATOLOGY, EXCIPIENTS, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, LITERATURE REVIEW

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
Sep/Oct 2012
Pg. 386-393

Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A
, Fokken Dawn
Sep/Oct 2009
Pg. 386-389

Pediatric Dermatitis
Remmert Renee
Nov/Dec 2002
Pg. 419-421

The Treatment of Canine Atopic Disease
Davidson Gigi S
May/Jun 2002
Pg. 210-215

Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A
, Fuhram L Clifton
Nov/Dec 1999
Pg. 496-500

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Zhang Yanping
, Trissel Lawrence A
May/Jun 2002
Pg. 226-229

Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 315

Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James
, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2004
Pg. 101-105

Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 336

In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie
, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014
Pg. 512-515

Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
Sep/Oct 2015
Pg. 405

Basics of Compounding for Dry-Skin Conditions
Allen Loyd V Jr
Nov/Dec 2003
Pg. 460-463

View Sample
Alkalizing Agents, Featured Excipient:
Allen Loyd V Jr
Sep/Oct 1999
Pg. 404-405

Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Earlywine Kerry
, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
Jan/Feb 2023
Pg. 6-10

Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat
, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017
Pg. 205-211

Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
Jan/Feb 2022
Pg. 55

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Potential Treatments for Radiation Dermatitis
Corsini Lindsay
May/Jun 2010
Pg. 210-213

Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
Jan/Feb 2011
Pg. 71

Return to Top